# Eugene Applebaum College of Pharmacy and Health Sciences

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/eugene-applebaum-college-of-pharmacy-and-health-sciences/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 57.5 |
| Citations | 171,146 |
| City | Detroit |
| Country | US |
| Description | Eugene Applebaum College of Pharmacy and Health Sciences is a research organisation in Detroit, US. OpenAlex records 1,909 works and 171,146 citations for it. 506 researchers list it as their most recent affiliation. |
| Homepage | http://cphs.wayne.edu/ |
| OpenAlex ID | https://openalex.org/I12311892 |
| Region | Michigan |
| Researchers | 506 |
| ROR ID | https://ror.org/0222p1e69 |
| Type | education |
| Wikidata ID | https://www.wikidata.org/wiki/Q5407033 |
| Works | 1,909 |

## University papers

- [Real-World Experience With Ceftazidime-Avibactam for Multidrug-Resistant Gram-Negative Bacterial Infections](https://scholariq.org/papers/real-world-experience-with-ceftazidime-avibactam-for-multidrug-resistant-gram/)
- [Bacteriophage Therapeutics: A Primer for Clinicians on Phage‐Antibiotic Combinations](https://scholariq.org/papers/bacteriophage-therapeutics-a-primer-for-clinicians-on-phage-antibiotic/)
- [On- and off-label utilization of dalbavancin and oritavancin for Gram-positive infections](https://scholariq.org/papers/on-and-off-label-utilization-of-dalbavancin-and-oritavancin-for-gram-positive/)
- [Long-Acting Lipoglycopeptides: “Lineless Antibiotics” for Serious Infections in Persons Who Use Drugs](https://scholariq.org/papers/long-acting-lipoglycopeptides-lineless-antibiotics-for-serious-infections-in/)
- [Bacteriophage-Antibiotic Combination Strategy: an Alternative against Methicillin-Resistant Phenotypes of Staphylococcus aureus](https://scholariq.org/papers/bacteriophage-antibiotic-combination-strategy-an-alternative-against-methicillin/)
- [Current therapies and challenges for the treatment of <i>Staphylococcus aureus</i> biofilm‐related infections](https://scholariq.org/papers/current-therapies-and-challenges-for-the-treatment-of-i-staphylococcus-aureus-i/)
- [Real-world, Multicenter Experience With Meropenem-Vaborbactam for Gram-Negative Bacterial Infections Including Carbapenem-Resistant <i>Enterobacterales</i> and <i>Pseudomonas aeruginosa</i>](https://scholariq.org/papers/real-world-multicenter-experience-with-meropenem-vaborbactam-for-gram-negative/)
- [Clinical Outcomes of Eravacycline in Patients Treated Predominately for Carbapenem-Resistant Acinetobacter baumannii](https://scholariq.org/papers/clinical-outcomes-of-eravacycline-in-patients-treated-predominately-for/)
- [Real-World Experience with Ceftolozane-Tazobactam for Multidrug-Resistant Gram-Negative Bacterial Infections](https://scholariq.org/papers/real-world-experience-with-ceftolozane-tazobactam-for-multidrug-resistant-gram/)
- [Early Experience With Eravacycline for Complicated Infections](https://scholariq.org/papers/early-experience-with-eravacycline-for-complicated-infections/)
- [Management of Gram‐Negative Bloodstream Infections With Oral Antibiotics in Solid Organ Transplant Recipients](https://scholariq.org/papers/management-of-gram-negative-bloodstream-infections-with-oral-antibiotics-in/)

## University researchers

- [Taylor Morrisette](https://scholariq.org/researchers/taylor-morrisette/)

## University top topics

Showing 8 of 25.

- [Antimicrobial Resistance in Staphylococcus](https://scholariq.org/topics/antimicrobial-resistance-in-staphylococcus/)
- [Antibiotics Pharmacokinetics and Efficacy](https://scholariq.org/topics/antibiotics-pharmacokinetics-and-efficacy/)
- [Antibiotic Resistance in Bacteria](https://scholariq.org/topics/antibiotic-resistance-in-bacteria/)
- [Bacterial Identification and Susceptibility Testing](https://scholariq.org/topics/bacterial-identification-and-susceptibility-testing/)
- [Antibiotic Use and Resistance](https://scholariq.org/topics/antibiotic-use-and-resistance/)
- [Pharmaceutical Practices and Patient Outcomes](https://scholariq.org/topics/pharmaceutical-practices-and-patient-outcomes/)
- [Nanoparticle-Based Drug Delivery](https://scholariq.org/topics/nanoparticle-based-drug-delivery/)
- [Pneumonia and Respiratory Infections](https://scholariq.org/topics/pneumonia-and-respiratory-infections/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.